Amundi increased its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 81.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,753,513 shares of the financial services provider’s stock after purchasing an additional 1,232,683 shares during the period. Amundi owned approximately 0.50% of Aflac worth $285,181,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new position in shares of Aflac during the fourth quarter worth $26,000. Darwin Wealth Management LLC purchased a new position in shares of Aflac during the third quarter worth $34,000. BankPlus Trust Department purchased a new position in shares of Aflac during the fourth quarter worth $34,000. Raelipskie Partnership acquired a new stake in Aflac during the third quarter valued at $38,000. Finally, Covestor Ltd grew its position in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after buying an additional 107 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently commented on AFL. Piper Sandler dropped their price target on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. BMO Capital Markets began coverage on shares of Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target on the stock. Wells Fargo & Company dropped their price target on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 19th. JPMorgan Chase & Co. raised their price target on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Finally, Morgan Stanley raised their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $103.36.
Insider Buying and Selling
In related news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.90% of the stock is currently owned by company insiders.
Aflac Stock Performance
AFL opened at $108.48 on Friday. The firm has a market capitalization of $59.29 billion, a PE ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50. The firm’s 50-day moving average price is $105.08 and its 200 day moving average price is $107.72. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, sell-side analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- Ride Out The Recession With These Dividend Kings
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Stocks to Buy While Others Stay on the Sidelines
- How to Use the MarketBeat Dividend Calculator
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.